全部 |
  • 全部
  • 题名
  • 作者
  • 机构
  • 关键词
  • NSTL主题词
  • 摘要
检索 二次检索 AI检索
外文文献 中文文献
筛选条件:

1. Determination of the Factor of Safety against Sliding of Finite Slopes Using Classical Regression and Soft Computing Approaches NSTL国家科技图书文献中心

Bahram Nourani |  Farzin Salmasi... -  《Iranian Journal of Science and Technology, Transaction of Civil Engineering》 - 2025,49(2) - 1715~1732 - 共18页

摘要:Determining the factor of safety against |  factor of safety (-F_(s LEM)) of finite slopes are |  sliding of slopes in engineering projects is a major |  an accurate estimation of sliding likelihood can be |  of this study, formulae based on classical
关键词: Slope Stability |  Factor of Safety |  Limit Equilibrium Method |  Gene Expression Programming |  Boosted Trees

2. Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review NSTL国家科技图书文献中心

Milling, Truman J. |  Voronov, Anna... -  《Thrombosis and Haemostasis》 - 2025,125(1) - 46~57 - 共12页

摘要: safety profile of a 4F-PCC (Kcentra (R)/Beriplex (R) P |  a favorable safety profile of 4F-PCC. Conclusion |  Analysis of postmarketing pharmacovigilance safety |  positive safety profile of 4F-PCC. | Introduction Four-factor prothrombin complex
关键词: four-factor prothrombin complex concentrate |  safety |  pharmacovigilance |  oral anticoagulant reversal

3. Prediction of the safety factor and the failure surface for slope stability analysis using Jaya optimization method NSTL国家科技图书文献中心

Emel Turker -  《Geomechanics and engineering》 - 2025,40(5) - 339~351 - 共13页

摘要: finding the minimum safety factor and the associated |  safety factors in slope stability analysis. Since |  equilibrium conditions of both force and moment and thus |  problem, Jaya algorithm, which is one of the many |  purpose of examining the performance and currency of
关键词: critical failure surface |  jaya optimization |  morgenstern-price method |  safety factor |  slope stability

4. Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review NSTL国家科技图书文献中心

Ishikawa, Takashi |  Nishimura, Kenichi... -  《Modern rheumatology》 - 2025,35(1) - 174~184 - 共11页

摘要: efficacy and safety of tumor necrosis factor (TNF |  registries (from 2000 to 2021). The risk of bias was |  assessed using the Cochrane Risk of Bias version 2 for |  randomized controlled trials (RCTs) and the manual of Minds | , the American College of Rheumatology pediatric (ACR
关键词: Adalimumab |  etanercept |  infliximab |  macrophage activation syndrome |  systemic JIA

5. Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review NSTL国家科技图书文献中心

Saultier, Paul |  Grino, Michel... -  《Haemophilia》 - 2025,31(1) - 7~15 - 共9页

摘要: investigate the effectiveness and safety of rFVIIa in |  effects, including the production of anti-GPIIb/IIIa |  transfusion refractoriness. Recombinant activated factor VII |  dosage of rFVIIa was consistent with previous |  managing 93% of non-surgical bleeds (n = 42), 91% of
关键词: antifibrinolytics |  antiplatelet antibodies |  Glanzmann thrombasthenia |  platelet refractoriness |  platelet transfusion |  rFVIIa

6. Simultaneous control of the electron temperature and safety factor profiles in DIII-D using model-based optimal control techniques NSTL国家科技图书文献中心

Morosohk, S. |  Wang, Z.... -  《Plasma physics and controlled fusion》 - 2025,67(1) - 共13页

摘要: regulation of both the electron temperature and safety |  and safety factor targets, including changes in both | . In order to enhance the robustness of the scenario | , feedback controllers for a variety of plasma properties |  ensure safe operation. However, only a limited set of
关键词: profile control |  neural network |  optimal control |  DIII-D

7. Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta-analysis NSTL国家科技图书文献中心

Li, Yafang |  Ding, Jin... -  《Acta pharmaceutica》 - 2025,75(1) - 23~40 - 共18页

摘要: efficacy and safety of vedolizumab and tumor necrosis |  estimates of efficacies and safety were calculated as |  safety of vedolizumab compared to TNF-alpha inhibitors |  factor-alpha (TNF-alpha) inhibitors for patients with |  Cochrane Library, and Web of Science. The pooled
关键词: vedolizumab |  TNF-alpha inhibitors |  inflammatory bowel disease |  ulcerative colitis

8. Fluid versus kinetic response to low- n magnetic perturbations in high- β HL-3 plasmas and effect of edge safety factor variation NSTL国家科技图书文献中心

Li, C. Y. |  Hao, G. Z.... -  《Plasma physics and controlled fusion》 - 2025,67(3) - 共16页

摘要: in edge safety factor for achieving ELM control at | -wall-limit), in contrast to strong suppression of the |  motions changes the growth rate of the relevant modes |  (mainly kink modes), thereby altering the strength of | -kinetic hybrid model indicate the presence of a window
关键词: RMP |  kinetic effect |  HL-3 |  high- beta N |  edge safety factor

9. Efficacy and Safety of Fibroblast Growth Factor 21 Analogues for Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis NSTL国家科技图书文献中心

Fabiana,Dolovitsch d... |  Samira Mohamad,Khali...... -  《Annals of Nutrition & Metabolism》 - 2025,81(1) - 51~60 - 共10页 - 被引量:1

摘要:). We aimed to compare the efficacy and safety of |  factor 21 (FGF21) analogues may benefit patients with |  stage without worsening of MASH and MASH resolution |  without worsening of fibrosis. Secondary outcomes were |  relative reduction ≥30% of the hepatic fat fraction (HFF
关键词: Metabolic-dysfunction-associated steatohepatitis |  Metabolic dysfunction-associated steatohepatitis |  Fibrosis |  Efficacy |  FGF21 analogues

10. Efficacy and Safety of Recombinant Factor VIII in Previously Untreated and Previously Treated Children with Hemophilia A: A Systematic Review NSTL国家科技图书文献中心

Feng, Xiaoqin |  Zhou, Xuan... -  《Advances in therapy.》 - 2025,42(5) - 2019~2039 - 共21页

摘要: efficacy and safety of standard (SHL) and extended half | ) undergoing recombinant factor VIII (rFVIII) therapy, yet |  PUPs. Here, EHL rFVIII showed a proportion of |  proportion of inhibitors at 36.4% (27.2%; 46.2%), with a |  high-titer proportion of 20.9% (12.9%; 30.3%) for the
关键词: Recombinant factor VIII |  Hemophilia A |  Pediatric |  Systematic review |  Inhibitor development
检索条件Factor of safety
  • 检索词扩展

NSTL主题词

  • NSTL学科导航